Factors Influencing the Properties of Rifampicin Liposome and Applications for Dry Powder Inhaler

@article{Changsan2007FactorsIT,
  title={Factors Influencing the Properties of Rifampicin Liposome and Applications for Dry Powder Inhaler},
  author={Narumon Changsan and Teerapol Srichana},
  journal={2007 2nd IEEE International Conference on Nano/Micro Engineered and Molecular Systems},
  year={2007},
  pages={1104-1109}
}
  • N. Changsan, T. Srichana
  • Published 2007
  • Materials Science
  • 2007 2nd IEEE International Conference on Nano/Micro Engineered and Molecular Systems
RIF encapsulated liposome vesicles were prepared by chloroform film method followed by freeze drying technique to obtain a dry powder for aerosol delivery. The freeze drying conditions were designed according to the DSC results of the liposome suspension. Three sugars (mannitol, lactose and trehalose) were used as a cryoprotectant of liposome dry powder. NR 8383 cell line was used to determine immunological activation and toxicity of liposome products when LPS from E.coli was used as a positive… Expand
1 Citations

Figures and Tables from this paper

Recent advances in liposomal dry powder formulations: preparation and evaluation
Liposomal drug dry powder formulations have shown many promising features for pulmonary drug administration, such as selective localization of drug within the lung, controlled drug release, reducedExpand

References

SHOWING 1-10 OF 29 REFERENCES
Liposome Encapsulated Rifampicin And lsoniazid
Rifampicin and isoniazid (INH) in combination were formulated into liposomes for utilization as a delivery system for optimum therapeutic use in tuberculosis. A modified lipid layer hydration methodExpand
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
TLDR
The results suggest that the ligand-anchored liposomal aerosols are not only effective in rapid attainment of high-drug concentration in lung with high population of alveolar macrophages but also maintain the same over prolonged period of time. Expand
Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
TLDR
Alginate microparticles containing antitubercular drugs resulted in up to a nine-fold increase in relative bioavailability compared with free drugs, suggesting that application of alginate-encapsulated drugs could be useful in the effective treatment of tuberculosis. Expand
Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers.
TLDR
Alginate-chitosan microspheres hold promise as a potential natural polymer-based oral ATD carrier for better management of TB. Expand
Stability of dry liposomes in sugar glasses.
TLDR
Solute leakage from dry liposomes was extremely slow at temperatures below the glass transition temperature (Tg); however, it increased exponentially as temperature increased to near or above the Tg, indicating that the glassy state had to be maintained for dryliposomes to retain trapped solutes. Expand
Liposomes and PLG microparticles as sustained release antitubercular drug carriers--an in vitro-in vivo study.
  • M. Dutt, G. Khuller
  • Medicine, Chemistry
  • International journal of antimicrobial agents
  • 2001
TLDR
Hepatotoxicity studies revealed no toxicity induced using biochemical tests, and liposomes and PLG microparticles exhibited a more sustained release of antitubercular drugs than a liposomal carrier system. Expand
Inhalable Microparticles Containing Drug Combinations to Target Alveolar Macrophages for Treatment of Pulmonary Tuberculosis
TLDR
Inhalable microparticles containing multiple anti-TB drugs offer promises of dose and dosing-frequency reduction, toxicity alleviation, and targeting Mφ-resident persistent mycobacteria. Expand
Use of Microsphere Technology for Targeted Delivery of Rifampin to Mycobacterium tuberculosis-Infected Macrophages
TLDR
It is demonstrated that rifampin-loaded microspheres can be formulated for effective sustained and targeted delivery to host macrophages and were more effective at reducing M. tuberculosis intracellular growth than equivalent doses of rifampsin given as a free drug. Expand
Respirable PLGA Microspheres Containing Rifampicin for the Treatment of Tuberculosis: Screening in An Infectious Disease Model
TLDR
Targeted delivery of rifampicin loaded microspheres to the alveolar macrophage, the host cell for Mycobacterium tuberculosis, may be an effective targeted approach to pulmonary tuberculosis therapy. Expand
Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.
TLDR
In vivo stability of these liposomes demonstrated the slow and controlled release of their encapsulated contents and encapsulated drugs also demonstrated reduced in vivo toxicity in comparison to free drug(s). Expand
...
1
2
3
...